{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:44:41Z","timestamp":1775897081174,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yichang Humanwell Pharmaceutical Co., Ltd., China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12325-025-03268-7","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:57:10Z","timestamp":1749531430000},"page":"4081-4088","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Remimazolam Besylate Versus Propofol for Short-Term Sedation in Critically Ill Patients Receiving Mechanical Ventilation: Protocol for a Multicenter Randomized Non-inferior Trial"],"prefix":"10.1007","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct05782894","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yun","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangzhi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"3","key":"3268_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jointm.2023.11.005","volume":"4","author":"S Berger","year":"2024","unstructured":"Berger S, Grzonka P, Amacher SA, Hunziker S, Frei AI, Sutter R. Adverse events related to physical restraint use in intensive care units: a review of the literature. J Intensive Med. 2024;4(3):318\u201325.","journal-title":"J Intensive Med"},{"issue":"9","key":"3268_CR2","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"issue":"1","key":"3268_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/CCM.0000000000003482","volume":"47","author":"BT Pun","year":"2019","unstructured":"Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for critically Ill patients with the ABCDEF bundle: results of the ICU liberation collaborative in over 15,000 adults. Crit Care Med. 2019;47(1):3\u201314.","journal-title":"Crit Care Med"},{"issue":"12","key":"3268_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1056\/NEJMe2001025","volume":"382","author":"C Gu\u00e9rin","year":"2020","unstructured":"Gu\u00e9rin C. Calming down about sedation in critically Ill patients. N Engl J Med. 2020;382(12):1162\u20134.","journal-title":"N Engl J Med"},{"issue":"45","key":"3268_CR5","doi-asserted-by":"publisher","first-page":"34781","DOI":"10.1074\/jbc.M110.143958","volume":"285","author":"MJM Fischer","year":"2010","unstructured":"Fischer MJM, Leffler A, Niedermirtl F, et al. The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem. 2010;285(45):34781\u201392.","journal-title":"J Biol Chem"},{"issue":"5","key":"3268_CR6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/00000542-199911000-00032","volume":"91","author":"B Langevin Paul","year":"1999","unstructured":"Langevin Paul B, Gravenstein N, Doyle Thomas J, et al. Growth of Staphylococcus aureus in Diprivan and Intralipid. Anesthesiology. 1999;91(5):1394\u2013400.","journal-title":"Anesthesiology"},{"issue":"1","key":"3268_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1213\/00000539-199901000-00039","volume":"88","author":"I Wachowski","year":"1999","unstructured":"Wachowski I, Jolly DT, Hrazdil J, Galbraith JC, Greacen M, Clanachan AS. The growth of microorganisms in propofol and mixtures of propofol and lidocaine. Anesth Analg. 1999;88(1):209\u201312.","journal-title":"Anesth Analg"},{"issue":"7","key":"3268_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2044.2007.05055.x","volume":"62","author":"PCA Kam","year":"2007","unstructured":"Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62(7):690\u2013701.","journal-title":"Anaesthesia"},{"key":"3268_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcrc.2021.04.001","volume":"64","author":"R Garcia","year":"2021","unstructured":"Garcia R, Salluh JIF, Andrade TR, et al. A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients. J Crit Care. 2021;64:91\u20139.","journal-title":"J Crit Care"},{"issue":"1","key":"3268_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, et al. Cns 7056. Anesthesiology. 2007;107(1):60\u20136.","journal-title":"Anesthesiology"},{"issue":"3","key":"3268_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","volume":"127","author":"T St\u00f6hr","year":"2021","unstructured":"St\u00f6hr T, Colin PJ, Ossig J, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127(3):415\u201323.","journal-title":"Br J Anaesth"},{"issue":"2","key":"3268_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056). Anesth Analg. 2012;115(2):274\u201383.","journal-title":"Anesth Analg"},{"issue":"4","key":"3268_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","volume":"42","author":"X Chen","year":"2020","unstructured":"Chen X, Sang N, Song K, et al. Psychomotor Recovery Following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote. Clin Ther. 2020;42(4):614\u201324.","journal-title":"Clin Ther"},{"key":"3268_CR14","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/CM9.0000000000002243","volume":"135","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Shu H, et al. Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study. Chin Med J. 2022;135:2134\u20136.","journal-title":"Chin Med J"},{"issue":"1","key":"3268_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-022-04168-w","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26(1):279.","journal-title":"Crit Care"},{"issue":"1","key":"3268_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13054-023-04760-8","volume":"27","author":"Y Tang","year":"2023","unstructured":"Tang Y, Gao X, Xu J, et al. Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study. Crit Care. 2023;27(1):474.","journal-title":"Crit Care"},{"issue":"5","key":"3268_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols. JAMA. 2018;319(5):483\u201394.","journal-title":"JAMA"},{"issue":"10","key":"3268_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond agitation-sedation scale. Am J Respir Crit Care Med. 2002;166(10):1338\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3268_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers. Anesthesiology. 2020;132(4):636\u201351.","journal-title":"Anesthesiology"},{"issue":"2","key":"3268_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Wiltshire","year":"2012","unstructured":"Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056). Anesth Analg. 2012;115(2):284\u201396.","journal-title":"Anesth Analg"},{"key":"3268_CR21","doi-asserted-by":"publisher","first-page":"938940","DOI":"10.3389\/fmed.2022.938940","volume":"9","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Gu W, Zhao M, Zhang Y, Wu J. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: a randomized trial. Front Med. 2022;9:938940.","journal-title":"Front Med"},{"issue":"11","key":"3268_CR22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.23736\/S0375-9393.22.16631-9","volume":"88","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, et al. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiol. 2022;88(11):939\u201349.","journal-title":"Minerva Anestesiol"},{"key":"3268_CR23","doi-asserted-by":"publisher","first-page":"735473","DOI":"10.3389\/fmed.2021.735473","volume":"8","author":"S Liu","year":"2021","unstructured":"Liu S, Su L, Zhang B, et al. The availability and safety study of remimazolam besylate for injection on sedation of ERAS patients under mechanical ventilation in ICU: protocol for a randomized, open-label, controlled trial. Front Med. 2021;8:735473.","journal-title":"Front Med"},{"key":"3268_CR24","doi-asserted-by":"publisher","first-page":"1139872","DOI":"10.3389\/fphar.2023.1139872","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang X, Tang Y, Du R, et al. Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial. Front Pharmacol. 2023;14:1139872.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3268_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s40001-023-01440-9","volume":"28","author":"Z Yao","year":"2023","unstructured":"Yao Z, Liao Z, Li G, Wang L, Zhan L, Xia W. Remimazolam tosylate\u2019s long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety. Eur J Med Res. 2023;28(1):452.","journal-title":"Eur J Med Res"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:02:57Z","timestamp":1757185377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3268"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03268-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yun Tang, Huaqing Shu, Lehao Ren, Ruiting Li, Xiaojing Zou, Hong Qi, Yaqi Ouyang, Yongran Wu, Jiqian Xu, Xiangzhi Fang, Xiaobo Yang and You Shang declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study has been approved by the ethics committees of all participating hospitals. The Ethics Committee of Wuhan Union Hospital is the central ethics committee (approval No. 2021\u20131069-01). This study will be conducted in accordance with the Helsinki declaration and the local legislation and institutional requirements. Written informed consent will be obtained from participants\u2019 legal representatives before enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}